tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Incyte Corp (INCY)
NASDAQ:INCY
US Market
INCY
Incyte
Overview
Analyst Forecasts
AI Stock Analysis
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Historical Prices
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Incyte (INCY) Stock News & Sentiment

Compare
1,710 Followers
Incyte’s Hold Rating: Balancing Pipeline Challenges and Established Product Valuation
Premium
Ratings
Incyte’s Hold Rating: Balancing Pipeline Challenges and Established Product Valuation
4d ago
INCY
Monday.com, Incyte, Lucid, Bloom, EQT: Trending by Analysts
Premium
Weekend Updates
Monday.com, Incyte, Lucid, Bloom, EQT: Trending by Analysts
6d ago
BE
EQT
Incyte’s Povorcitinib Shows Promise but Faces Competitive and Market Challenges, Leading to Hold Rating
Premium
Ratings
Incyte’s Povorcitinib Shows Promise but Faces Competitive and Market Challenges, Leading to Hold Rating
9d ago
INCY
Incyte’s Stock Downgraded to Sell Amid Disappointing Drug Data and Market Challenges
Premium
Ratings
Incyte’s Stock Downgraded to Sell Amid Disappointing Drug Data and Market Challenges
9d ago
INCY
Incyte’s Promising Phase 3 Results and Market Potential Drive Buy Rating
Premium
Ratings
Incyte’s Promising Phase 3 Results and Market Potential Drive Buy Rating
10d ago
INCY
Buy Rating for Incyte’s Povorcitinib Despite Mixed Trial Results, Highlighting Potential in Biologic-Experienced Subgroups
Premium
Ratings
Buy Rating for Incyte’s Povorcitinib Despite Mixed Trial Results, Highlighting Potential in Biologic-Experienced Subgroups
10d ago
INCY
Opzelura’s Promising Market Potential Despite Trial Inconsistencies: Analyst’s Perspective
Premium
Ratings
Opzelura’s Promising Market Potential Despite Trial Inconsistencies: Analyst’s Perspective
15d ago
INCY
More INCY News >

INCY News on the Web

Is Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) a Strong ETF Right Now?
Zacks
Neutral
Analysts Offer Insights on Healthcare Companies: InflaRx (IFRX), Eli Lilly & Co (LLY) and Incyte (INCY)
TipRanks News
Neutral
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
Zacks
Neutral
Incyte (INCY) was downgraded to a Hold Rating at William Blair
TipRanks News
Neutral
Monday.com, Incyte, Lucid, Bloom, EQT: Trending by Analysts
TipRanks News
Neutral
BB Biotech AG Reduces Stake in Black Diamond Therapeutics Inc
GuruFocus News
Neutral
Baker Bros. Advisors LP Increases Stake in Immunocore Holdings PLC
GuruFocus News
Neutral
The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics
Zacks
Neutral

News Score - Last 7 Days

Neutral
INCY
Sector Average
Media Buzz
This Week8 articles
Weekly Average9.75 articles
News Sentiment
This Week50%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is INCY’s Media Buzz Sentiment?
8 articles about INCY were published this week. In an average week, 9.75 articles are published.
    What is INCY’s weekly average amount of articles?
    In an average week, 9.75 articles about INCY are published.
      What is INCY’s News Sentiment?
      50% of articles about INCY were positive this week, compared to its sector average of 62%.
        Healthcare Stocks that are Trending in the News
        ALCAlcon
        SLNOSoleno Therapeutics
        BHCBausch Health Companies
        DYAIDyadic International
        ASMBAssembly Biosciences
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing